DYNAPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dynapen, and what generic alternatives are available?
Dynapen is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in DYNAPEN is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dynapen
A generic version of DYNAPEN was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DYNAPEN?
- What are the global sales for DYNAPEN?
- What is Average Wholesale Price for DYNAPEN?
Summary for DYNAPEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 4,571 |
| DailyMed Link: | DYNAPEN at DailyMed |
US Patents and Regulatory Information for DYNAPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | DYNAPEN | dicloxacillin sodium | FOR SUSPENSION;ORAL | 050337-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
